{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:04:12Z","timestamp":1793315052706,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Suleyman Demirel University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Trauma Emerg Surg"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>One of the important causes of morbidity and mortality in the world is traumatic brain injury (TBI), which is a process that triggers damaging mechanisms such as inflammation, oxidative stress, and apoptosis. The results of current pharmaceutical methods are not enough, and researches into new therapy modalities are needed. This study aimed to evaluate the neuroprotective effects of Urapidil (Ura), which is an alpha-1 adrenergic receptor antagonist with serotonergic activity, in a TBI model and investigating signaling pathways like high mobility group box 1 (HMGB1), BCL2-interacting protein 3-like (BNIP3L), and hypoxia-inducible factor-1 alpha (HIF1\u03b1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Thirty-two rats were divided into four groups: control, TBI, TBI\u2009+\u2009Ura\n                      <jats:sub>0.5<\/jats:sub>\n                      (0.5\u00a0mg\/kg), TBI\u2009+\u2009Ura\n                      <jats:sub>5<\/jats:sub>\n                      (5\u00a0mg\/kg) groups. Tissue integrity and expressions of tumor necrosis factor-alpha (TNF-\u03b1), caspase-3 (Cas-3), tyrosine hydroxylase (TH), HIF1\u03b1, BNIP3L, and HMGB1 were assessed. Ura\u2019s biochemical oxidative stress indicators were also assessed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ura treatment at both doses, significantly decreased histopathological findings, BNIP3L, HMGB1, and HIF1\u03b1 expressions, TNF-\u03b1, Cas-3, TH immunexpressions, and TOS and OSI levels, and elevated TAS levels compared to TBI group. These results show that Ura regulates molecular pathways related to TBI, including neuroinflammation, mitochondrial dysfunction, and hypoxia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Ura shows promising tissue-protective effects in TBI by targeting inflammation, oxidative stress, and apoptosis. This study provides a new perspective on the need for further development of Ura for therapeutic use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00068-025-02873-z","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T08:42:03Z","timestamp":1746520923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Urapidil as a neuroprotective agent: targeting hypoxia, inflammation, and oxidative stress in traumatic brain injury"],"prefix":"10.1007","volume":"51","author":[{"given":"Ahmet","family":"Bindal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u0131nar","family":"Karabacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"Asci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilter","family":"Ilhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammet Yusuf","family":"Tepebasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Abdulkadir","family":"Sevuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3850-0137","authenticated-orcid":false,"given":"Orhan","family":"Imeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Ozmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"2873_CR1","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/J.TIPS.2010.09.005","volume":"31","author":"DJ Loane","year":"2010","unstructured":"Loane DJ, Faden AI. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci. 2010;31:596\u2013604. https:\/\/doi.org\/10.1016\/J.TIPS.2010.09.005.","journal-title":"Trends Pharmacol Sci"},{"key":"2873_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/0963689717714102","volume":"26","author":"MG G","year":"2017","unstructured":"G MG T, X Q, et al. Traumatic brain injury: current treatment strategies and future endeavors. Cell Transpl. 2017;26:83\u2013118. https:\/\/doi.org\/10.1177\/0963689717714102.","journal-title":"Cell Transpl"},{"key":"2873_CR3","doi-asserted-by":"publisher","first-page":"109619","DOI":"10.1016\/J.INTIMP.2022.109619","volume":"114","author":"Y Gao","year":"2023","unstructured":"Gao Y, Zhang H, Wang J, et al. Annexin A5 ameliorates traumatic brain injury-induced neuroinflammation and neuronal ferroptosis by modulating the NF-\u0138B\/HMGB1 and Nrf2\/HO-1 pathways. Int Immunopharmacol. 2023;114:109619. https:\/\/doi.org\/10.1016\/J.INTIMP.2022.109619.","journal-title":"Int Immunopharmacol"},{"key":"2873_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1177\/0963689719840353\/ASSET\/IMAGES\/LARGE\/10.1177_0963689719840353-FIG6.JPEG","volume":"28","author":"J Ma","year":"2019","unstructured":"Ma J, Ni H, Rui Q, et al. Potential roles of NIX\/BNIP3L pathway in rat traumatic brain injury. Cell Transpl. 2019;28:585\u201395. https:\/\/doi.org\/10.1177\/0963689719840353\/ASSET\/IMAGES\/LARGE\/10.1177_0963689719840353-FIG6.JPEG.","journal-title":"Cell Transpl"},{"key":"2873_CR5","doi-asserted-by":"publisher","first-page":"696","DOI":"10.4103\/1673-5374.206632","volume":"12","author":"M Khan","year":"2017","unstructured":"Khan M, Khan H, Singh I, Singh AK. Hypoxia inducible factor-1 alpha stabilization for regenerative therapy in traumatic brain injury. Neural Regen Res. 2017;12:696\u2013701. https:\/\/doi.org\/10.4103\/1673-5374.206632.","journal-title":"Neural Regen Res"},{"key":"2873_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12974-018-1151-3\/FIGURES\/8","volume":"15","author":"X Chen","year":"2018","unstructured":"Chen X, Chen C, Fan S, et al. Omega-3 polyunsaturated fatty acid attenuates the inflammatory response by modulating microglia polarization through SIRT1-mediated deacetylation of the HMGB1\/NF-\u039aB pathway following experimental traumatic brain injury. J Neuroinflammation. 2018;15:1\u201315. https:\/\/doi.org\/10.1186\/S12974-018-1151-3\/FIGURES\/8.","journal-title":"J Neuroinflammation"},{"key":"2873_CR7","doi-asserted-by":"publisher","first-page":"e395329","DOI":"10.1590\/ACB395329","volume":"39","author":"R \u00c7etin","year":"2024","unstructured":"\u00c7etin R, Bahadir S, Basar \u0130, et al. Neuroprotective effects of the combined treatment of Resveratrol and urapidil in experimental cerebral ischemia-reperfusion injury in rats. Acta Cir Bras. 2024;39:e395329. https:\/\/doi.org\/10.1590\/ACB395329.","journal-title":"Acta Cir Bras"},{"key":"2873_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3171\/JNS.1994.80.2.0291","volume":"80","author":"A Marmarou","year":"1994","unstructured":"Marmarou A, Abd-Elfattah Foda MA, Van den Brink W, et al. A new model of diffuse brain injury in rats. Part I: pathophysiology and biomechanics. J Neurosurg. 1994;80:291\u2013300. https:\/\/doi.org\/10.3171\/JNS.1994.80.2.0291.","journal-title":"J Neurosurg"},{"key":"2873_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.22038\/IJBMS.2021.57196.12736","volume":"24","author":"MC G\u00fcler","year":"2021","unstructured":"G\u00fcler MC, Tanyeli A, Erdo\u011fan DG, et al. Urapidil alleviates ovarian torsion detorsion injury via regulating oxidative stress, apoptosis, autophagia, and inflammation. Iran J Basic Med Sci. 2021;24:935\u201342. https:\/\/doi.org\/10.22038\/IJBMS.2021.57196.12736.","journal-title":"Iran J Basic Med Sci"},{"key":"2873_CR10","doi-asserted-by":"publisher","first-page":"e0227349","DOI":"10.1371\/JOURNAL.PONE.0227349","volume":"15","author":"D Mielke","year":"2020","unstructured":"Mielke D, Bleuel K, Stadelmann C, et al. The ESAS-score: A histological severity grading system of subarachnoid hemorrhage using the modified double hemorrhage model in rats. PLoS ONE. 2020;15:e0227349. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0227349.","journal-title":"PLoS ONE"},{"key":"2873_CR11","doi-asserted-by":"publisher","unstructured":"\u0130lhan \u0130, Asc\u0131 H, Buyukbayram H\u0130, et al. The impact of the High-Fructose corn syrup on cardiac damage via SIRT1\/PGC1-\u03b1 pathway: potential ameliorative effect of selenium. Biol Trace Elem Res. 2024;202. https:\/\/doi.org\/10.1007\/S12011-024-04081-Z.","DOI":"10.1007\/S12011-024-04081-Z"},{"key":"2873_CR12","doi-asserted-by":"publisher","unstructured":"Ng SY, Lee AYW. Traumatic brain injuries: pathophysiology and potential therapeutic targets. Front Cell Neurosci. 2019;13. https:\/\/doi.org\/10.3389\/FNCEL.2019.00528.","DOI":"10.3389\/FNCEL.2019.00528"},{"key":"2873_CR13","doi-asserted-by":"publisher","unstructured":"Choi YK. Detrimental roles of Hypoxia-Inducible Factor-1\u03b1 in severe hypoxic brain diseases. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/IJMS25084465.","DOI":"10.3390\/IJMS25084465"},{"key":"2873_CR14","doi-asserted-by":"publisher","unstructured":"Godoy DA, Rubiano AM, Paranhos J, et al. Avoiding brain hypoxia in severe traumatic brain injury in settings with limited resources - A pathophysiological guide. J Crit Care. 2023;75. https:\/\/doi.org\/10.1016\/J.JCRC.2023.154260.","DOI":"10.1016\/J.JCRC.2023.154260"},{"key":"2873_CR15","doi-asserted-by":"publisher","unstructured":"Li Y, Zheng W, Lu Y, et al. BNIP3L\/NIX-mediated mitophagy: molecular mechanisms and implications for human disease. Cell Death Dis. 2021;13. https:\/\/doi.org\/10.1038\/S41419-021-04469-Y.","DOI":"10.1038\/S41419-021-04469-Y"},{"key":"2873_CR16","doi-asserted-by":"publisher","first-page":"1460286","DOI":"10.3389\/FIMMU.2024.1460286","volume":"15","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Zhang J, Deng Q, Chen X. Mitophagy-associated programmed neuronal death and neuroinflammation. Front Immunol. 2024;15:1460286. https:\/\/doi.org\/10.3389\/FIMMU.2024.1460286.","journal-title":"Front Immunol"},{"key":"2873_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/ITT.S58064","volume":"4","author":"E Ranzato","year":"2015","unstructured":"Ranzato E, Martinotti S, Patrone M. Emerging roles for HMGB1 protein in immunity, inflammation, and cancer. Immunotargets Ther. 2015;4:101. https:\/\/doi.org\/10.2147\/ITT.S58064.","journal-title":"Immunotargets Ther"},{"key":"2873_CR18","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/EJI.200424916","volume":"34","author":"HE Harris","year":"2004","unstructured":"Harris HE, Andersson U. Mini-review: the nuclear protein HMGB1 as a Proinflammatory mediator. Eur J Immunol. 2004;34:1503\u201312. https:\/\/doi.org\/10.1002\/EJI.200424916.","journal-title":"Eur J Immunol"},{"key":"2873_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1089\/NEU.2017.5155","volume":"35","author":"EP Thelin","year":"2018","unstructured":"Thelin EP, Hall CE, Gupta K, et al. Elucidating Pro-Inflammatory cytokine responses after traumatic brain injury in a human stem cell model. J Neurotrauma. 2018;35:341\u201352. https:\/\/doi.org\/10.1089\/NEU.2017.5155.","journal-title":"J Neurotrauma"},{"key":"2873_CR20","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/J.CELREP.2018.01.089","volume":"22","author":"A Iannielli","year":"2018","unstructured":"Iannielli A, Bido S, Folladori L, et al. Pharmacological Inhibition of necroptosis protects from dopaminergic neuronal cell death in Parkinson\u2019s disease models. Cell Rep. 2018;22:2066\u201379. https:\/\/doi.org\/10.1016\/J.CELREP.2018.01.089.","journal-title":"Cell Rep"},{"key":"2873_CR21","doi-asserted-by":"publisher","unstructured":"Bouhamida E, Morciano G, Perrone M, et al. The interplay of hypoxia signaling on mitochondrial dysfunction and inflammation in cardiovascular diseases and cancer: from molecular mechanisms to therapeutic approaches. Biology (Basel). 2022;11. https:\/\/doi.org\/10.3390\/BIOLOGY11020300.","DOI":"10.3390\/BIOLOGY11020300"},{"key":"2873_CR22","doi-asserted-by":"publisher","unstructured":"Ye J, Hu X, Wang Z, et al. The role of mtdamps in the trauma-induced systemic inflammatory response syndrome. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/FIMMU.2023.1164187.","DOI":"10.3389\/FIMMU.2023.1164187"}],"container-title":["European Journal of Trauma and Emergency Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00068-025-02873-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00068-025-02873-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00068-025-02873-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:03:58Z","timestamp":1770721438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00068-025-02873-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2873"],"URL":"https:\/\/doi.org\/10.1007\/s00068-025-02873-z","relation":{},"ISSN":["1863-9933","1863-9941"],"issn-type":[{"value":"1863-9933","type":"print"},{"value":"1863-9941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The procedures conducted on rats were subjected to review and approval by the Animal Experiments Local Ethics Committee of Suleyman Demirel University (Ethic No: 11.05.2023-05\/167). The experiment adhered to the Animal Research: Reporting of In Vivo Experiments (ARRIVE) 2.0 guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"During the preparation of this work the authors used ChatGPT-4o to improve language and readability. After using this tool\/service, the authors reviewed and edited the content as needed and took full responsibility for the content of the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"196"}}